Prof. Eric Bouteiller quoted in Les Echoes story on China's emergence as a leader in the pharmaceutical sector.

In a world shaped by rapid innovation and shifting priorities, healthcare companies are being tested on their ability to remain agile, adaptive, and driven by purpose.

In an eventful year for global business, numerous CEIBS faculty offered their invaluable insights on many of the key trends that shaped the world of enterprise in 2024. Here are ten of the most popular pieces published by CEIBS professors in 2024.

The global pharmaceutical sector still struggles to balance accessibility against incentivising innovation for new drugs to fight disease, experts heard at an industry event on CEIBS Shanghai campus recently.

China’s large population of 1.4bn means it can act as an R&D centre for trials of drugs targeting rare diseases, Prof Eric Bouteiller tells the Economist.

The CEIBS International Summit on Social Security and Aging Finance was successfully held at the school’s Shanghai campus recently, with numerous distinguished speakers and experts in the field invited to participate under the theme of “Global Perspective and the Chinese Approach: Sustainable Development of China’s Unique Social Security System.”

CEIBS hosted a healthcare seminar with Professor of Management Eric Bouteiller in central Paris on June 1.

The CEIBS Innovation Forum 2022 series kicked off in Shenzhen today with a focus on economic and talent development in Guangdong-Hong Kong-Macao Greater Bay Area.

Product innovation and a focus on customer feedback play crucial roles for building global brands, according to Amazon Vice President, Head of Asia Global Selling Cindy Tai.

A new facility launched by CEIBS will boost the development of Shanghai as a smart city and contribute to improving public healthcare in China and beyond, according to CEIBS President Wang Hong.

The 2019 CEIBS MBA Healthcare Investment Forum took place today with a full house at the CEIBS Petrochemical Auditorium on the Shanghai Campus.